TR200000116T2 - Anestetik bir bileşiğin berrak, enjekte edilebilen formülasyonu - Google Patents

Anestetik bir bileşiğin berrak, enjekte edilebilen formülasyonu

Info

Publication number
TR200000116T2
TR200000116T2 TR2000/00116T TR200000116T TR200000116T2 TR 200000116 T2 TR200000116 T2 TR 200000116T2 TR 2000/00116 T TR2000/00116 T TR 2000/00116T TR 200000116 T TR200000116 T TR 200000116T TR 200000116 T2 TR200000116 T2 TR 200000116T2
Authority
TR
Turkey
Prior art keywords
clear
injectable formulation
anesthetic compound
anesthetic
compound
Prior art date
Application number
TR2000/00116T
Other languages
English (en)
Inventor
De Tommaso Vincenzo
Original Assignee
Westy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Westy Ag filed Critical Westy Ag
Publication of TR200000116T2 publication Critical patent/TR200000116T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Propofolü, bir öd asidinin farmasötik açidan kabul görür bir tuzunu ve bir lesitini içeren, sulu, enjekte edilebilir farmasötik formülasyon.
TR2000/00116T 1997-05-26 1998-05-14 Anestetik bir bileşiğin berrak, enjekte edilebilen formülasyonu TR200000116T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH01224/97A CH692322A5 (it) 1997-05-26 1997-05-26 Formulazione iniettabile limpida di Propofol.

Publications (1)

Publication Number Publication Date
TR200000116T2 true TR200000116T2 (tr) 2000-05-22

Family

ID=4205400

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00116T TR200000116T2 (tr) 1997-05-26 1998-05-14 Anestetik bir bileşiğin berrak, enjekte edilebilen formülasyonu

Country Status (23)

Country Link
US (1) US6326406B1 (tr)
EP (1) EP0991405B1 (tr)
JP (1) JP2001527577A (tr)
KR (1) KR20010013011A (tr)
CN (1) CN1268051A (tr)
AR (1) AR012853A1 (tr)
AT (1) ATE230984T1 (tr)
AU (1) AU735020B2 (tr)
BR (1) BR9809492A (tr)
CA (1) CA2291261A1 (tr)
CH (1) CH692322A5 (tr)
DE (1) DE69810771D1 (tr)
DZ (1) DZ2503A1 (tr)
HU (1) HUP0002117A3 (tr)
IN (1) IN187550B (tr)
MY (1) MY132911A (tr)
NO (1) NO995831L (tr)
PA (1) PA8451701A1 (tr)
PE (1) PE75299A1 (tr)
PL (1) PL337026A1 (tr)
TR (1) TR200000116T2 (tr)
WO (1) WO1998053805A1 (tr)
ZA (1) ZA984314B (tr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
JP4198318B2 (ja) 1998-08-19 2008-12-17 ヤーゴテック アクチェンゲゼルシャフト プロポフォールの注射可能水性分散物
CN1151782C (zh) * 1999-01-28 2004-06-02 迪内希·尚蒂拉尔·帕特尔 一种具有哺乳动物麻醉的诱导和保持以及镇静用途的药用注射液
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US6635456B2 (en) * 2001-02-09 2003-10-21 Fidia Farmaceutici S.P.A. Procedure for the preparation of pure phosphatides with phospholipase D
US6803046B2 (en) * 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
KR100482269B1 (ko) * 2002-10-08 2005-04-14 센츄론(주) 2,6-디이소프로필페놀을 활성성분으로 하는 수용액상의마취용 주사제 및 그 제조방법
EP1585548B1 (en) 2002-12-09 2018-06-27 Abraxis BioScience, LLC Compositions and methods of delivery of pharmacological agents
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US8546453B2 (en) * 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
JP2005154305A (ja) * 2003-11-21 2005-06-16 Showa Yakuhin Kako Kk ヒアルロン酸含有組成物の製造方法
CN100358513C (zh) * 2005-04-07 2008-01-02 常州市第四制药厂有限公司 一种丙泊酚注射液的制备工艺
US8034765B2 (en) 2005-08-31 2011-10-11 Abraxis Bioscience, Llc Compositions and methods for preparation of poorly water soluble drugs with increased stability
BRPI0615265A8 (pt) 2005-08-31 2018-03-06 Abraxis Bioscience Llc composições compreendendo agentes farmacêuticos pouco hidrossoluíveis e agentes antimicrobianos
NZ590802A (en) * 2008-11-20 2013-05-31 Techno Guard Co Ltd Formulation comprising a pyrazolone derivative and an amphiphilic solubilising agent
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations
WO2019173526A1 (en) * 2018-03-07 2019-09-12 Andrew Xian Chen Aqueous formulations for insoluble drugs
JP7063217B2 (ja) * 2018-09-27 2022-05-09 住友電気工業株式会社 光ファイバの製造方法
JP7135670B2 (ja) * 2018-09-27 2022-09-13 住友電気工業株式会社 光ファイバ及び紫外線硬化型樹脂組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1089510B (de) * 1959-03-23 1960-09-22 Rudolf Reiss Dr Verfahren zur Herstellung waessriger, injizierbarer Loesungen von 2-Methoxy-4-allylphenoxyessigsaeure-N, N-Diaethylamid
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
DE3221579A1 (de) * 1982-06-08 1983-12-22 Eckert, Theodor, Prof. Dr., 4400 Münster Solubilisierung von in wasser schwerloeslichen wirkstoffen in waessrige loesung unter verwendung eines gemisches von cholinphosphorsaeureglycerindiester (cholin-lecithin) und natriumdesoxycholat als loesungsvermittler und die therapeutische verwendung der so erhaltenen waessrigen loesungen
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
US5085864A (en) * 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
DE4039602A1 (de) * 1990-12-12 1992-06-17 Bauer Kurt Heinz Prof Dr Pharmazeutische formulierungen
GB9405593D0 (en) 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
ZA962214B (en) 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition
AU6708096A (en) * 1995-09-18 1997-04-09 Vesifact Ag Propofol nanodispersions
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations

Also Published As

Publication number Publication date
JP2001527577A (ja) 2001-12-25
NO995831L (no) 2000-01-26
HUP0002117A2 (hu) 2000-12-28
DZ2503A1 (fr) 2005-01-25
MY132911A (en) 2007-10-31
PL337026A1 (en) 2000-07-31
WO1998053805A1 (en) 1998-12-03
EP0991405B1 (en) 2003-01-15
AU8209798A (en) 1998-12-30
DE69810771D1 (de) 2003-02-20
ZA984314B (en) 1998-12-08
ATE230984T1 (de) 2003-02-15
AU735020B2 (en) 2001-06-28
US6326406B1 (en) 2001-12-04
CH692322A5 (it) 2002-05-15
EP0991405A1 (en) 2000-04-12
NO995831D0 (no) 1999-11-26
AR012853A1 (es) 2000-11-22
PA8451701A1 (es) 2000-05-24
PE75299A1 (es) 1999-08-26
CN1268051A (zh) 2000-09-27
CA2291261A1 (en) 1998-12-03
IN187550B (tr) 2002-05-18
BR9809492A (pt) 2000-06-20
KR20010013011A (ko) 2001-02-26
HUP0002117A3 (en) 2001-04-28

Similar Documents

Publication Publication Date Title
ATE282600T1 (de) Salpetersäuresalze von antihypertensiven arzneimitteln
MY132911A (en) Clear, injectable solution of an anesthetic compound
FI961059A0 (fi) Protonipumppuinhibiittoria sisältävä tabletoitu moniyksikköannostusmuoto
PL341054A1 (en) Novel suppositiories containing an active compound being unstable in acid environments
DE69732049D1 (de) Pharmazeutische zubereitungen, enthaltend salze von hyaluronsäure und lokalanästhetika
EP1685839B8 (en) Pharmaceutical oral dosage form comprising a combination of an opioid agonist and opioid antagonist
PT1295600E (pt) Medicamento com base em gestagenios que contem acido ascorbico e/ou sais do mesmo para uma aplicacao dermica
ATE260646T1 (de) Schnell zerfallende orale dosierungsform
ATE448782T1 (de) Pharmazeutische glutathionpräparate und methoden zu dern verabreichung
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
PT1123120E (pt) Formulacao medicinal em aerossol
HN1999000158A (es) Sistemas de entrega controlado de droga administrado oralmente que provee control temporal y espacial
IS1950B (is) Arýlsúlfonýlamínó hýdroxamsýruafleiður, notkun þeirra, ásamt lyfjablöndum
TR200001645T2 (tr) Retinoyik asit taklidi anilürler.
DE60027575D1 (de) Verwendung von Spinosad oder einer Zusammensetzung enthaltend spinosad
TR199902175T2 (tr) Parasetamol içeren yutma tableti.
EE05054B1 (et) 5-HT4 agonisti v?i antagonisti peroraalne ravimkoostis ja selle kasutamine meditsiinis
BR9509975A (pt) Formulação farmacêutica
NL192304B (nl) Noötropisch geneesmiddel dat als werkzaam bestanddeel een pyroglutaminezuuramidederivaat bevat en een dergelijk pyroglutaminezuuramidederivaat.
CO4940452A1 (es) Modificacion a cristal de una sustancia activa de medicamen- to
GT199800196A (es) Combinaciones de estatina-eter carboxialquilico.
BR9812443A (pt) 1-2-3-4-5-6-hexahidro-2,6-metano-3-benzazocin-10-óis substituìdos, processos para sua preparação e seu emprego como medicamentos
AR010359A1 (es) Grupo heterociclico sustituido; antagonista de receptores de endotelina que lo comprende; derivado de acido carbonico heterociclico que lo incluye;combinaciones y preparaciones de medicamentos de este ultimo.
MY114428A (en) New pharmacological use of aii-receptor antagonists
NO943070L (no) Antitussiva